Edgewise Therapeutics, Inc. Business Finance Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement between Edgewise Therapeutics, Inc. and Leerink Partners LLC for Sale of Common Stock
Underwriting Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
NY
2025
Underwriting Agreement between Edgewise Therapeutics, Inc. and Leerink Partners LLC for Sale of Common Stock
Underwriting Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
NY
2024
Sales Agreement for Up to $125,000,000 Common Stock Between Edgewise Therapeutics, Inc. and BofA Securities, Inc.
Equity Distribution Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
NY
2023
Edgewise Therapeutics, Inc. 2021 Equity Incentive Plan Restricted Stock Unit Agreement
Equity Distribution Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
CO
2023
Underwriting Agreement between Edgewise Therapeutics, Inc. and J.P. Morgan Securities LLC, SVB Securities LLC (September 2022)
Underwriting Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
NY
2022
Description of Capital Stock and Registration Rights of eFFECTOR Therapeutics, Inc.
Registration Rights Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
2022
Underwriting Agreement between Edgewise Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and SVB Leerink LLC
Underwriting Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
NY
2021
Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan
Equity Distribution Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
DE
2021
Edgewise Therapeutics, Inc. Specimen Common Stock Certificate
Stock Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
2021
Edgewise Therapeutics, Inc. 2017 Equity Incentive Plan (as Amended November 30, 2020)
Equity Distribution Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
CA
2021
Amended and Restated Investors’ Rights Agreement by and among Edgewise Therapeutics, Inc. and Investors (December 3, 2020)
Investor Rights Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
DE
2021